{
    "Trade/Device Name(s)": [
        "GLUCOCARD\u00ae VitalTM Blood Glucose Monitoring System",
        "GLUCOCARD\u00ae VitalTM Blood Glucose Meter",
        "GLUCOCARD\u00ae VitalTM Blood Glucose Test Strips",
        "Assure Dose CONTROL"
    ],
    "Submitter Information": "ARKRAY Factory USA, Inc.",
    "510(k) Number": "K091102",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063068"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "September 9, 2009",
    "Summary Letter Received Date": "September 10, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [
        "Test strip"
    ],
    "Instrument(s)/Platform(s)": [
        "GLUCOCARD\u00ae VitalTM Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "In Vitro diagnostic"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for GLUCOCARD\u00ae VitalTM Blood Glucose Monitoring System for quantitative glucose measurement in fresh capillary whole blood.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips and palms, for home OTC use or clinical settings to monitor effectiveness of diabetes control; not for diagnosis/screening of diabetes or for neonates.",
    "fda_folder": "Clinical Chemistry"
}